Lafleur & Godfrey LLC Decreased Perrigo Company LTD (PRGO) Stake as Stock Value Declined

April 17, 2018 - By Nellie Frank

Perrigo Company plc (NYSE:PRGO) LogoInvestors sentiment increased to 1.07 in Q4 2017. Its up 0.28, from 0.79 in 2017Q3. It improved, as 43 investors sold PRGO shares while 126 reduced holdings. 73 funds opened positions while 107 raised stakes. 102.69 million shares or 8.39% less from 112.10 million shares in 2017Q3 were reported. Pinebridge Invests Ltd Partnership reported 5,744 shares stake. Aviva Public Llc has invested 0.04% in Perrigo Company plc (NYSE:PRGO). Caisse De Depot Et Placement Du Quebec has invested 0% of its portfolio in Perrigo Company plc (NYSE:PRGO). 56,176 are held by British Columbia Investment Mngmt Corp. Rbf Cap Limited Liability Corp accumulated 4,000 shares. Dupont Cap stated it has 1,198 shares. 56 were accumulated by Endurance Wealth Inc. Franklin Res holds 8.10M shares or 0.34% of its portfolio. Spirit Of America Corporation Ny owns 1,300 shares or 0.01% of their US portfolio. Cubist Systematic Strategies Limited Liability Corp has 0.05% invested in Perrigo Company plc (NYSE:PRGO) for 10,307 shares. Paloma Prtnrs Mgmt Co holds 10,175 shares or 0.01% of its portfolio. Shamrock Asset Mngmt Ltd Liability Co reported 0.02% in Perrigo Company plc (NYSE:PRGO). National Bank Of America De holds 0% in Perrigo Company plc (NYSE:PRGO) or 159,389 shares. Denver Limited Liability Corp owns 112,184 shares or 0.49% of their US portfolio. Riverhead Cap Mngmt Ltd Liability Company owns 375 shares or 0% of their US portfolio.

Lafleur & Godfrey Llc decreased its stake in Perrigo Company Ltd (PRGO) by 93.48% based on its latest 2017Q4 regulatory filing with the SEC. Lafleur & Godfrey Llc sold 36,342 shares as the company’s stock declined 5.84% with the market. The institutional investor held 2,534 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $221,000, down from 38,876 at the end of the previous reported quarter. Lafleur & Godfrey Llc who had been investing in Perrigo Company Ltd for a number of months, seems to be less bullish one the $11.62B market cap company. The stock increased 1.23% or $1 during the last trading session, reaching $82.47. About 263,803 shares traded. Perrigo Company plc (NYSE:PRGO) has risen 18.43% since April 17, 2017 and is uptrending. It has outperformed by 6.88% the S&P500.

Analysts await Perrigo Company plc (NYSE:PRGO) to report earnings on May, 29. They expect $1.14 EPS, up 8.57 % or $0.09 from last year’s $1.05 per share. PRGO’s profit will be $160.60 million for 18.09 P/E if the $1.14 EPS becomes a reality. After $1.28 actual EPS reported by Perrigo Company plc for the previous quarter, Wall Street now forecasts -10.94 % negative EPS growth.

Perrigo Company plc (NYSE:PRGO) Ratings Coverage

Among 11 analysts covering Perrigo Company plc (NYSE:PRGO), 6 have Buy rating, 0 Sell and 5 Hold. Therefore 55% are positive. Perrigo Company plc had 14 analyst reports since October 27, 2017 according to SRatingsIntel. The stock has “Buy” rating by Cantor Fitzgerald on Friday, March 2. Canaccord Genuity maintained the stock with “Buy” rating in Tuesday, February 27 report. Jefferies maintained it with “Hold” rating and $81.0 target in Thursday, November 9 report. Cantor Fitzgerald maintained Perrigo Company plc (NYSE:PRGO) rating on Wednesday, November 15. Cantor Fitzgerald has “Buy” rating and $107.0 target. On Friday, November 10 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. The rating was maintained by RBC Capital Markets on Sunday, March 4 with “Hold”. The stock of Perrigo Company plc (NYSE:PRGO) earned “Buy” rating by Argus Research on Friday, December 8. JP Morgan maintained it with “Neutral” rating and $83 target in Monday, March 5 report. Jefferies maintained the shares of PRGO in report on Friday, October 27 with “Hold” rating. Oppenheimer maintained the stock with “Buy” rating in Monday, March 5 report.

Perrigo Company plc (NYSE:PRGO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.